Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
| Language | Translation |
|---|---|
English
|
Wiskott-Aldrich syndrome |
French
|
Syndrome de Wiskott-Aldrich |
| Level | Code | Title | |
|---|---|---|---|
| 1 | III | Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism | |
| 2 | D80-D89 | Certain disorders involving the immune mechanism | |
| 3 | D82 | Immunodeficiency associated with other major defects | |
| 4 | D82.0 | Wiskott-Aldrich syndrome |
| Active Ingredient | Description | |
|---|---|---|
| Eltrombopag |
Endogenous thrombopoietin (TPO) is the main cytokine involved in regulation of megakaryopoiesis and platelet production, and is the endogenous ligand for the TPO-R. Eltrombopag interacts with the transmembrane domain of the human TPO-R and initiates signalling cascades similar but not identical to that of endogenous thrombopoietin (TPO), inducing proliferation and differentiation from bone marrow progenitor cells. |
|
| Human normal immunoglobulin G |
Human normal immunoglobulin contains mainly immunoglobulin G (IgG) with a broad spectrum of antibodies against infectious agents. Human normal immunoglobulin contains the IgG antibodies present in the normal population. It is usually prepared from pooled plasma from not fewer than 1000 donors. |
|
| Immunoglobulins, normal human, IV |
Human normal immunoglobulin contains mainly immunoglobulin G (IgG) with a broad spectrum of antibodies against infectious agents. The mechanism of action in indications other than replacement therapy is not fully elucidated, but includes immunomodulatory effects. |
